These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26383712)

  • 1. INTRAVITREAL SULFUR HEXAFLUORIDE INJECTION FOR THE TREATMENT OF VITREOMACULAR TRACTION SYNDROME.
    Day S; Martinez JA; Nixon PA; Levitan M; Dooner JW; Wong RW; Harper CA
    Retina; 2016 Apr; 36(4):733-7. PubMed ID: 26383712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumatic release of focal vitreomacular traction.
    Claus MG; Feron E; Veckeneer M
    Eye (Lond); 2017 Mar; 31(3):411-416. PubMed ID: 27813527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
    Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Injection of Perfluoropropane is More Efficacious than Sulfur Hexafluoride In Releasing Vitreomacular Traction.
    Čokl N; Globočnik Petrovič M
    Acta Clin Croat; 2018 Jun; 57(2):327-334. PubMed ID: 30431727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole].
    Lenk J; Matthé E; Ventzke S; Pillunat LE; Sandner D
    Klin Monbl Augenheilkd; 2018 Jan; 235(1):73-80. PubMed ID: 28282697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome.
    Özdemir HB; Özdek Ş; Hasanreisoğlu M
    Turk J Ophthalmol; 2019 Sep; 49(4):201-208. PubMed ID: 31486607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction.
    Rodrigues IA; Stangos AN; McHugh DA; Jackson TL
    Am J Ophthalmol; 2013 Feb; 155(2):270-276.e2. PubMed ID: 23164159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences].
    Maier M; Abraham S; Frank C; Feucht N; Lohmann CP
    Ophthalmologe; 2015 Dec; 112(12):990-4. PubMed ID: 26062717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
    Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL
    Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes.
    Sharma P; Juhn A; Houston SK; Fineman M; Chiang A; Ho A; Regillo C
    Am J Ophthalmol; 2015 May; 159(5):861-7.e2. PubMed ID: 25660387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded?
    Manousaridis K; Peter-Reichart S; Mennel S
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1907-1916. PubMed ID: 28681138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome.
    Singh RP; Li A; Bedi R; Srivastava S; Sears JE; Ehlers JP; Schachat AP; Kaiser PK
    Br J Ophthalmol; 2014 Mar; 98(3):356-60. PubMed ID: 24357495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.
    Theodossiadis GP; Grigoropoulos VG; Theodoropoulou S; Datseris I; Theodossiadis PG
    Am J Ophthalmol; 2014 Apr; 157(4):842-851.e1. PubMed ID: 24445034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature.
    Neffendorf JE; Simpson ARH; Steel DHW; Desai R; McHugh DA; Pringle E; Jackson TL
    Acta Ophthalmol; 2018 Nov; 96(7):685-691. PubMed ID: 28857483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study.
    Khanani AM; Duker JS; Heier JS; Kaiser PK; Joondeph BC; Kozma P; Rosberger DF; MacCumber M; Boyer DS; Pieramici DJ
    Ophthalmol Retina; 2019 Jan; 3(1):32-41. PubMed ID: 30935657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flare changes after intravitreal injection of ocriplasmin in symptomatic vitreomacular traction syndrome.
    Pirani V; Pelliccioni P; Cesari C; Carrozzi G; Cavallero E; Mariotti C
    Jpn J Ophthalmol; 2019 May; 63(3):255-261. PubMed ID: 30805734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.
    Schumann RG; Langer J; Compera D; Luedtke K; Schaumberger MM; Kreutzer T; Mayer WJ; Wolf A; Priglinger SG
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2081-2089. PubMed ID: 28755165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INTRAVITREAL OCRIPLASMIN IN CLINICAL PRACTICE: Predictors of Success, Visual Outcomes, and Complications.
    Feng HL; Roth DB; Hasan A; Fine HF; Wheatley HM; Prenner JL; Shah SP; Modi KK; Feuer WJ
    Retina; 2018 Jan; 38(1):128-136. PubMed ID: 28106706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.
    Paul C; Heun C; Müller HH; Hoerauf H; Feltgen N; Wachtlin J; Kaymak H; Mennel S; Koss MJ; Fauser S; Maier MM; Schumann RG; Mueller S; Chang P; Schmitz-Valckenberg S; Kazerounian S; Szurman P; Lommatzsch A; Bertelmann T
    Br J Ophthalmol; 2018 Aug; 102(8):1092-1097. PubMed ID: 29089354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin.
    Warrow DJ; Lai MM; Patel A; Raevis J; Berinstein DM
    Am J Ophthalmol; 2015 Jan; 159(1):20-30.e1. PubMed ID: 25220823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.